🔗 Share this article

Chancellor Rachel Reeves has stated she is planning "focused steps to deal with household expense issues" in the forthcoming financial statement.

In comments to media outlets, she emphasized that lowering price rises is a collective responsibility of both the government and the central bank.

The UK's price growth is projected to be the highest among the G7 industrialized countries this year and next.

Possible Energy Cost Interventions

It is understood the government could take action to bring down utility costs, such as by cutting the present 5% rate of VAT applied on energy supplies.

A further possibility is to cut some of the government charges presently included in household expenses.

Budgetary Constraints and Analyst Expectations

The administration will obtain the latest draft from the official forecaster, the Office for Budget Responsibility, on the start of the week, which will reveal how much scope there is for these actions.

The view from the majority of economists is that Reeves will have to introduce tax increases or spending cuts in order to meet her self-imposed debt limits.

Previously on the same day, estimates indicated there was a twenty-two billion pound shortfall for the chancellor to address, which is at the more modest range of projections.

"There's a shared job between the central bank and the government to bear down further on some of the causes of inflation," Reeves informed the BBC in the US capital, at the conferences of the International Monetary Fund and World Bank.

Revenue Pledges and International Concerns

While much of the attention has been on probable tax rises, the Treasury chief said the most recent information from the fiscal watchdog had not altered her pledge to manifesto promises not to raise tax levels on earnings tax, VAT or National Insurance.

She attributed an "unpredictable world" with growing international and commercial concerns for the Budget tax moves, likely to be directed on those "wealthiest."

Global Trade Disputes

Commenting on apprehensions about the United Kingdom's trade ties with China she said: "Our security interests invariably take priority."

Recent announcement by China to tighten trade restrictions on rare earths and other resources that are key for advanced tech production led American leader the US President to suggest an further 100% tariff on goods from the Asian country, raising the risk of an all-out commercial conflict between the two largest economies.

The US Treasury Secretary labeled China's action "economic coercion" and "a international production power grab."

Inquired about accepting the US offer to join its battle with China, the Chancellor said she was "very concerned" by China's measures and encouraged the Beijing authorities "to avoid restrictions and limit trade."

She said the action was "bad for the international commerce and causes additional headwinds."

"It is my opinion there are sectors where we need to confront Chinese policies, but there are also important opportunities to export to Chinese markets, including banking sector and other sectors of the economic system. We've got to achieve that balance appropriate."

The Treasury chief also confirmed she was cooperating with other major economies "on our own critical minerals approach, so that we are less reliant."

NHS Drug Costs and Investment

Reeves also admitted that the price the National Health Service spends on medicines could go up as a consequence of ongoing negotiations with the Trump administration and its pharmaceutical firms, in exchange for reduced taxes and investment.

Some of the world's largest drug companies have said recently that they are either delaying or canceling operations in the United Kingdom, with some blaming the modest returns they are receiving.

Last month, the government science advisor said the cost the health service spends on drugs would need to go up to stop companies and pharmaceutical investment departing from the United Kingdom.

Reeves told the BBC: "We have seen as a result of the payment system, that medical research, new drugs have not been provided in the UK in the extent that they are in other continental states."

"We want to ensure that patients getting treatment from the NHS are can receive the best life-saving medicines in the world. And so we are reviewing these issues, and... seeking to secure additional capital into the UK."